231 related articles for article (PubMed ID: 32024728)
1. Performance Characteristics of a Multiplex Flow Immunoassay for Detection of IgG-Class Antibodies to Measles, Mumps, Rubella, and Varicella-Zoster Viruses in Presumptively Immune Health Care Workers.
Theel ES; Sorenson M; Rahman C; Granger D; Vaughn A; Breeher L
J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 32024728
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Bio-Rad BioPlex Measles, Mumps, Rubella, and Varicella-Zoster Virus IgG multiplex bead immunoassay.
Binnicker MJ; Jespersen DJ; Rollins LO
Clin Vaccine Immunol; 2011 Sep; 18(9):1524-6. PubMed ID: 21795463
[TBL] [Abstract][Full Text] [Related]
3. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
[TBL] [Abstract][Full Text] [Related]
4. Detection of IgG-class antibodies to measles, mumps, rubella, and varicella-zoster virus using a multiplex bead immunoassay.
Dhiman N; Jespersen DJ; Rollins LO; Harring JA; Beito EM; Binnicker MJ
Diagn Microbiol Infect Dis; 2010 Aug; 67(4):346-9. PubMed ID: 20638602
[TBL] [Abstract][Full Text] [Related]
5. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save?
Alp E; Cevahir F; Gökahmetoglu S; Demiraslan H; Doganay M
J Infect Public Health; 2012 Apr; 5(2):127-32. PubMed ID: 22541258
[TBL] [Abstract][Full Text] [Related]
6. Field Test and Validation of the Multiplier Measles, Mumps, Rubella, and Varicella-Zoster Multiplexed Assay System in the Democratic Republic of the Congo by Using Dried Blood Spots.
Higgins SG; Hoff NA; Gadoth A; Fusellier A; Mukadi P; Alfonso V; Randall C; Ashbaugh H; Poncheri M; Doshi RH; Gerber S; Budd R; Wolfert R; Williams R; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Rimoin AW
mSphere; 2019 Aug; 4(4):. PubMed ID: 31413172
[TBL] [Abstract][Full Text] [Related]
7. Prevaccination antibody screening and immunization program for healthcare personnel against measles, mumps, rubella, and varicella in a Japanese tertiary care hospital.
Kanamori H; Tokuda K; Ikeda S; Endo S; Ishizawa C; Hirai Y; Takahashi M; Aoyagi T; Hatta M; Gu Y; Yano H; Weber DJ; Kaku M
Tohoku J Exp Med; 2014 Oct; 234(2):111-6. PubMed ID: 25224029
[TBL] [Abstract][Full Text] [Related]
8. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?
Celikbas A; Ergonul O; Aksaray S; Tuygun N; Esener H; Tanir G; Eren S; Baykam N; Guvener E; Dokuzoguz B
Am J Infect Control; 2006 Nov; 34(9):583-7. PubMed ID: 17097453
[TBL] [Abstract][Full Text] [Related]
9. Calibration and Evaluation of Quantitative Antibody Titers for Varicella-Zoster Virus by Use of the BioPlex 2200.
McLachlan E; Scholz H; Bolotin S; Crowcroft NS; Hatchette TF; Jackson C; Severini A;
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167847
[TBL] [Abstract][Full Text] [Related]
10. Measles, Mumps, Rubella, and Varicella Zoster Virus Serology and Infections in Solid Organ Transplant Recipients During the First Year Posttransplantation.
Rezahosseini O; Sørensen SS; Perch M; Ekenberg C; Møller DL; Knudsen AD; Kirkby N; Lundgren J; Lodding IP; Wareham NE; Gustafsson F; Rasmussen A; Nielsen SD
Clin Infect Dis; 2021 Dec; 73(11):e3733-e3739. PubMed ID: 32564061
[TBL] [Abstract][Full Text] [Related]
11. Pre-vaccination IgG screening for mumps is the most cost-effectiveness immunization strategy among Health Care Workers.
Coppeta L; Balbi O; Baldi S; Pietroiusti A; Magrini A
Hum Vaccin Immunother; 2019; 15(5):1135-1138. PubMed ID: 30779686
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan.
Hatakeyama S; Moriya K; Itoyama S; Nukui Y; Uchida M; Shintani Y; Morisawa Y; Kimura S
Infect Control Hosp Epidemiol; 2004 Jul; 25(7):591-4. PubMed ID: 15301032
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan.
Asari S; Deguchi M; Tahara K; Taniike M; Toyokawa M; Nishi I; Watanabe M; Iwatani Y; Makimoto K
Am J Infect Control; 2003 May; 31(3):157-62. PubMed ID: 12734521
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
Ödemiş Í; Köse Ş; Akbulut Í; Albayrak H
Rev Esp Quimioter; 2019 Dec; 32(6):525-531. PubMed ID: 31642641
[TBL] [Abstract][Full Text] [Related]
16. Immunity of nursing students to measles, mumps, rubella, and varicella in Yozgat, Turkey.
Kader Ç; Erbay A; Akça NK; Polat MF; Polat S
Am J Infect Control; 2016 Jan; 44(1):e5-7. PubMed ID: 26442461
[TBL] [Abstract][Full Text] [Related]
17. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.
Nolan T; McIntyre P; Roberton D; Descamps D
Vaccine; 2002 Dec; 21(3-4):281-9. PubMed ID: 12450703
[TBL] [Abstract][Full Text] [Related]
18. Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries.
Prymula R; Povey M; Brzostek J; Cabrnochova H; Chlibek R; Czajka H; Leviniene G; Man S; Neamtu M; Pazdiora P; Plesca D; Ruzkova R; Stefkovicova M; Usonis V; Verdanova D; Wysocki J; Casabona G; Habib MA
Vaccine; 2021 May; 39(19):2643-2651. PubMed ID: 33858718
[TBL] [Abstract][Full Text] [Related]
19. Effect of vaccine program on IgG antibody titers for measles, rubella, varicella, and mumps in young adults in Japan: Survey between 2018 and 2021.
Miyazaki H; Yamanaka G; Furukawa K; Ichiki M
J Infect Chemother; 2022 Oct; 28(10):1410-1414. PubMed ID: 35779802
[TBL] [Abstract][Full Text] [Related]
20. Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?
Llenas-García J; Rubio R; Hernando A; Arrazola P; Pulido F
AIDS Care; 2013 Aug; 25(8):980-9. PubMed ID: 23244745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
